Clinical Trial Update: Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for mitoxantrone HCL liposome injection in relapsed diffuse large B-cell lymphoma and PT/NKCLs (per ClinicalTrials.gov).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Peripheral T-cell Nk-cell Lymphoma

Drugs mentioned

• mitoxantrone HCL liposome injection (mitoxantrone liposomal hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Relapsed DLBCL and PT/NKCLs | Phase 2 | Status: UNKNOWN